Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Wednesday, 20 October 2021, 16:01 HKT/SGT
Share:
BNP Morningstar Initiates Coverage of CCMGT (9982.HK) with "BUY" rating

HONG KONG, Oct 20, 2021 - (ACN Newswire) - BNP Morningstar initiated coverage of Central China Management (9982.HK) with "BUY" rating and set its target price at HKD 3.92 per share for the following reasons:

Project management services for the real estate sector have taken off recently in China, driven by rising land costs and increasing competition that sees small and midsize developers seek the services of project managers with established brands to help derive higher returns on their projects. According to the research report, Central China Management Company, as a leading project manager in China with a strong presence in Henan province, is expected to benefit from industry growth of 23% over the next five years.

The Bank also expects that as the industry expands, there will be more spin-offs of project management units by smaller national and larger regional real estate developers given the attractive profitability. With the new entrants, the market share of leading companies' such as CCMGT should remain high over the next five years.

BNP Morningstar is of the view that CCMGT can be regarded as a more defensive proxy to China's real estate growth given its asset-light business model. Moreover, the Bank thinks it is noteworthy to see relatively stronger growth given demand for its services.

The research report mentions that CCMGT attributes their competitive advantage in Henan to the following key factors: 1) strong recognition of the Jianye brand; 2) well established and deep understanding of the Henan real estate market; 3) ability to provide a full suite of services; 4) a strong network of resources--namely designers, suppliers, contractors and others to work on the projects; and 5) ability to pass on completed projects to Central China New Life, the group's property management service entity, to ensure the quality of the projects will be sustained.

The report adds that CCMGT's strategy is to focus on maintaining its dominance in Henan and to sustain its profit margin. Since the penetration rate is still low for the industry at 3%-5%, moving up to around 9% by 2025. It is reasonable to assume that CCMGT will be able to sustain a decent profit level despite the prospect of new entrants to the industry. CCMGT has the luxury of being able to select the project it thinks it is better able to add value to. This is the other reason that should allow CCMGT to keep a fairly stable profit margin in the near term.

BNP Morningstar estimates that it is possible for upside to the profit forecast of CCMGT if the company's ex-Henan projects take off. CCMGT is looking to acquire local teams to its business as it pushes into neighboring provinces. If so, profitability is likely to be more resilient.

The downdraft in China's real estate sector on the Evergrande debt contagion concerns, places CCMGT at very attractive levels. The shares are trading at lows since listing on 31 May 2021 with a share price of HKD 1.2-1.3, placing the shares at 3.64-3.94 times 2022 price/earnings.



Topic: Press release summary Sectors: Real Estate & REIT
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Latest Press Releases
HKTDC unveils gifts, printing, packaging and licensing events  
Apr 27, 2024 20:00 HKT/SGT
Masverse Unveils Groundbreaking Blockchain Platform  
Apr 27, 2024 02:40 HKT/SGT
Spritzer Scores Big with 'Meet the Red Legends' Event for Football Fans  
Apr 26, 2024 23:00 HKT/SGT
Announcing Mad About Marketing - A New Member of the Digital Sukoon Private Limited Family  
Apr 26, 2024 22:25 HKT/SGT
FinTech Funding Continues to Surge as Second Edition of Dubai FinTech Summit Commences  
Apr 26, 2024 21:10 HKT/SGT
TIME Interconnect Technology Limited Announces Final Results For The Nine Months Ended 31 December 2023  
Apr 26, 2024 18:26 HKT/SGT
UK advertising reports GBP36.6bn spend in 2023  
Apr 26, 2024 17:30 HKT/SGT
CanSinoBIO CSO Shares the Latest Results of the Company's Globally Innovative Pneumococcal Vaccine  
Apr 26, 2024 15:36 HKT/SGT
Edvantage Group Announces FY2024 Interim Results  
Apr 26, 2024 13:43 HKT/SGT
Internationally Renowned Botulinum Toxin Experts Join WizMedi Bio's New Botulinum Toxin Development Project  
Apr 26, 2024 13:27 HKT/SGT
More Press release >>
 Events:
More >>
 News Alerts
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: